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The present thesis describes the potential of targeting the endocrine regulation 
of adipocyte lipolysis in human obesity treatment and prevention. An 
appropriate adipose tissue lipid metabolism is imperative to maintain normal 
adipose tissue function in human metabolically compromised conditions like 
obesity or type 2 diabetes mellitus. The valorization potential of the current 
results will be described in terms of social and economic relevance and 
implications for specific target groups and future innovative development.  
Social and economic relevance of the obesity epidemic 
Currently, our society is facing an alarming increase of overweight and obesity 
prevalence, which even extends to developing countries. According to latest 
statistics of the World Health Organisation (2014), Europe had the second 
highest proportion of individuals with overweight or obesity, preceded by the 
Americas. In Belgium and the Netherlands, 67% and 49% of the adult 
population deals with overweight and even 22% and 14% are diagnosed with 
obesity, respectively. The future perspectives on the development of obesity are 
disconcerting since it is predicted that the number of individuals with obesity will 
increase even more in the next two decades. This is a perplexing trend as 
individuals with obesity are more prone to develop metabolic diseases, 
cardiovascular diseases, mental disorders and certain types of cancer. Moreover, 
obesity (together with obesity-related complications) will further hamper efforts 
for healthcare cost management and thus not only affects public health but also 
has major socio-economic consequences. Therefore, new or optimized strategies 
for treatment and prevention are warranted to counteract this global obesity 
epidemic. Obtaining more insights into the adipose tissue physiology, and in 
particular adipose tissue lipid metabolism, is crucial with respect to treatment 
optimization and therefore was the main focus of the current thesis.   
Development of obesity and obesity-related health complications 
Obesity results from a chronic positive energy balance in which energy intake 
exceeds energy expenditure. Consequently, the energy surplus is stored within 
the adipose tissue, which gradually expands and may result in adipose tissue 
dysfunction. The main pillars of restoring the energy balance are reducing 
energy intake in relation to energy expenditure and increasing energy 
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expenditure. However, despite diet intervention being one of the most studied 
interventions in obesity treatment, many people often cannot maintain their 
initial weight loss due to a high relapse (weight regain) rate in this type of 
interventions. Contrarily, stimulating energy expenditure could be a suitable 
alternative to restore or even create a negative energy balance, in which 
increased physical activity or exercise is a common used strategy. Despite the 
efficacy of exercise, with respect to induce weight loss and promote healthier 
metabolic outcomes, many people often have difficulties maintaining regular 
physical activity regimes in their everyday life, ultimately limiting weight loss 
and in particular limiting weight maintenance after weight loss. Furthermore, the 
observed biomechanical anomalies often present in the obese state frequently 
hamper the ability to perform physical exercise. Developing alternative 
(combinational) strategies to improve clinical efficacy (i.e. maximizing weight 
loss and restoring metabolic complications) in the obese state are therefore 
imperative. With respect to weight loss, the stimulation of adipocyte lipolysis, a 
physiological process that is tightly regulated in an endocrine manner, is 
essential to reduce adipose tissue mass in the context of a negative energy 
balance.  
Long-term regulation and control of body weight (body composition) relies upon 
a large regulatory network integrating different metabolic organs, in which the 
white adipose tissue is the major place for long-term energy storage in the form 
of triacylglycerol in adipocytes. In obesity, the chronic positive energy balance 
enlarges the adipocytes which may lead to an impaired lipid buffering capacity of 
the adipose tissue, which together with intrinsic lipolytic impairments may be 
identified as putative key factors in the pathophysiology of obesity and obesity-
related metabolic and cardiometabolic complications. Gaining better insight into 
the role of these anomalies in obesity pathophysiology as well as lipolytic 
endocrine regulation is warranted in human metabolically compromised 
conditions. Therefore, in this thesis we explored whether natriuretic peptides, 
and in particular atrial natriuretic peptide (ANP), are substantially involved in the 
physiological regulation of adipocyte lipolysis in the obese insulin resistant state. 
Moreover, another goal was to explore the effect(s) of combined exercise 
intervention on this endocrine regulation system. As confirmed in the present 
thesis, there is now significant evidence that ANP in involved in the regulation of 
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adipocyte lipolysis, especially in the abdominal subcutaneous adipose tissue. 
However, in the obese insulin resistant or obese diabetic state, adipose tissue 
lipolysis displays a catecholamine- and ANP-resistant phenotype, which was not 
improved upon exercise intervention in the obese insulin resistant state. 
Therefore, finding appropriate strategies to alleviate the observed lipolytic 
impairments in the obese insulin resistant state are of major importance for 
body weight control and to improve adipose tissue function and metabolic profile 
in humans with obesity and thus more research in humans is required.  
Target groups 
Given the development of obesity associated metabolic disease affecting millions 
of people in our current societies, finding strategies to prevent and treat 
overweight, obesity and obesity-related health risks are crucial to improve global 
health and to counteract exploding healthcare costs. Indeed, in the obese state, 
even modest weight loss might lead to substantial beneficial health effects. 
Therefore, optimizing clinical efficacy of intervention programs, in terms of 
adipose tissue mass reduction and metabolic health, are of primary interest. In 
this respect, developing strategies, which are able to restore known lipolytic 
impairments present in the obese insulin resistant adipose tissue could be of 
major interest. To develop targeted exercise interventions or better 
pharmacological therapies should include fundamental as well as clinical work in 
human individuals with obesity and/or obesity-related metabolic complications.  
In order to tackle obesity development, and in particular the development of its 
associated metabolic diseases like type 2 diabetes mellitus and cardiovascular 
disease, health care professionals, health institutions (including hospital 
settings, rehabilitation and sports centers), governments and general society 
need to be informed about these targeted exercise or combinational treatment 
(e.g. lifestyle intervention including exercise, diet and/or pharmaceutical 
treatments) strategies. In science, the aim is to make results available for the 
scientific community and health professionals through publication in 
international peer-reviewed journals and presentation on (inter)national 
scientific meetings. However, translation of scientific knowledge to society is 
essential. Beyond academia and scientific journals and meetings, our research 
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has been published in newspapers which enabled us to reach a broader audience 
to take notice of our findings. In this thesis, by performing in vitro work and 
clinical intervention studies with human subjects, we demonstrated a 
pronounced attenuation of ANP-mediated lipolysis in the abdominal 
subcutaneous adipocytes of obese individuals. The physiological relevance of this 
pathway in adipose tissue lipolysis was confirmed in the obese state as well, 
although exercise intervention could not restore the observed anomaly. Yet, 
exercise training in individuals with obesity or its combination with partial 
pharmacological inhibition of adipose tissue lipolysis in patients with type 2 
diabetes was shown to modulate whole-body insulin sensitivity. Thus, the results 
presented in this thesis are of clinical relevance for a large number of people and 
therefore may be used by health care professionals to optimize lifestyle 
programs for individuals with overweight or obesity. In order to stimulate the 
translation of these findings to society and obtain awareness and support from 
the general public or policy makers, communicating these observations outside 
science is of considerable importance. Of interest, next to lifestyle and 
behavioral intervention to target obesity or its metabolic complications, 
pharmacological (co)interventions may be an alternative to alleviate adipose 
tissue function in the obese state. Targeting adipose tissue lipid metabolism or 
adipocyte function via pharmaceutical agents requires a good understanding and 
collaboration between universities and the pharmaceutical industry.  
Activities and products 
The research described in this thesis has been conducted at the department of 
Human Biology (Maastricht University), the Rehabilitation Research Center 
(Hasselt University) in collaboration with Heart Center Hasselt and Abdominal 
Surgery of Jessa Hospital and Hospital East-Limburg (Belgium). This unique 
collaboration between Universities and hospitals is a good example of how basic 
science can be performed in a hospital setting, combining knowledge of 
scientists and medical specialists across boarders. The collaboration between 
basic scientists and professionals involved in obesity management is essential 
given that the current applied physical activity modalities in obesity 
rehabilitation, which are applied very frequent at both aforementioned hospital 
departments, might not be appropriate to restore adipose tissue function in 
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these patients. In order to increase the knowledge on white adipose tissue 
function and thereby improve prevention and/or treatment of human 
metabolically compromised conditions, strong national and international 
collaboration between different disciplines is of utmost importance. 
The results described in this thesis are published or will be published in original 
research articles in scientific journals in the field of obesity and diabetes. 
Accordingly, these articles can be found online (accessible to those interested). 
The present results help to understand white adipose tissue physiology in 
humans and can be used for future studies on exploring optimized strategies to 
combat the obesity epidemic. The key role of adipose tissue function in 
metabolic health is currently subject of debate in the field of obesity research. 
The main outcomes of this thesis provide evidence for recommending the 
importance of a proper regulation of adipose tissue lipid metabolism in order to 
maintain a ‘healthy’ adipose tissue function. Moreover, this thesis showed that 
exercise training was not able to improve adipose tissue lipolysis despite 
improvements in metabolic disturbances, indicating the need for substantial 
weight loss to further restore adipose tissue function. However, the 
repercussions of adipose tissue depot- and sex-specific effects on adipocyte 
function, as well as the relationship to cardiometabolic health and the efficacy of 
diet/exercise intervention are important aspects, which require further research. 
This might also imply that stratification of individuals with obesity based on 
metabolic health characteristics is necessary to optimize and create tailored 
prevention and treatment strategies.  
Innovation 
By combining state-of-the-art in vivo clinical research and laboratory analyses, 
we were able to investigate for the first time the contribution of ANP in the 
regulation of adipocyte lipolysis in individuals with obesity. Moreover, the use of 
exercise intervention was shown to be insufficient to restore the observed 
impaired adipocyte lipolysis regulation in the obese insulin resistant state, 
leaving some opportunities for future research (as described in Chapter 6 and 7 
of this thesis).  
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The current findings indicate a possible important role of non-adrenergically 
mediated lipolysis, most likely (partly) mediated by ANP, especially during 
physical activity or exercise. Together with the observations of the presence of a 
putative natriuretic deficiency in metabolic disease (as described in Chapter 2), 
this might indicate that the natriuretic peptide system or some of their 
components (e.g. their receptors or downstream mediators at the level of the 
adipose tissue) are candidate drug targets with therapeutic potential in obesity 
and type 2 diabetes, population in which poor adherence to lifestyle intervention 
is frequently observed. However, the therapeutic potential should be explored 
guardedly in future research, with special attention to cardiovascular 
complications. Of interest, efficient and selective (i.e. adipose tissue specific) 
ANP receptor agonists and antagonists are warranted to firmly delineate the 
physiological relative contribution of the different lipolytic agents in adipocyte 
lipolysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
